Two Individual IMAT Investigators Leverage Technologies To Receive Prestigious NIH Director's Transformative R01 Awards



Two IMAT investigators who have developed specific technologies through the program have continued to succeed in leveraging those technologies to meet scientific needs and applications within other NIH programs.  Dr. Benjamin Cravatt from the Scripps Research Institute and Dr. Shohei Koide from the Unversity of Chicago both successfully received recent Transformative-R01 awards as part of the NIH Roadmap/Common Fund focusing on high-risk, high-impact research. Read more about the NIH Common Fund and Transformative-R01 mechanism here.